Risk factors for cisplatin-induced long-term nephrotoxicity in pediatric cancer survivors

Arga M., Oguz A., PINARLI F. G., KARADENİZ C., Citak E. C., Emeksiz H. C., ...More

PEDIATRICS INTERNATIONAL, vol.57, no.3, pp.406-413, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 57 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.1111/ped.12542
  • Journal Name: PEDIATRICS INTERNATIONAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.406-413
  • Gazi University Affiliated: Yes

Abstract

BackgroundThe aim of this study was to compare the nephrotoxicity risk of cisplatin (CPL) and ifosfamide (IFO) combination treatment (CT) with that of CPL alone and to evaluate the prevalence of CPL-induced long-term nephrotoxicity in pediatric cancer survivors (CS).